Literature DB >> 31240236

External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals.

Sameer S Kadri1, Yi Ling Elaine Lai2, Emily E Ricotta2, Jeffrey R Strich1,3, Ahmed Babiker4, Chanu Rhee5,6, Michael Klompas5,6, John P Dekker7, John H Powers8, Robert L Danner1, Jennifer Adjemian2,3.   

Abstract

Difficult-to-treat resistance (DTR; ie, co-resistance to all first-line antibiotics) in gram-negative bloodstream infection (GNBSI) is associated with decreased survival in administrative data models. We externally validated DTR prevalence and associated mortality risk in GNBSI using detailed clinical data from electronic health records to adjust for baseline differences in acute illness severity.

Keywords:  antimicrobial resistance; gram-negative bacteria; mortality

Year:  2019        PMID： 31240236      PMCID： PMC6441782          DOI： 10.1093/ofid/ofz110

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   3.835


  14 in total

1.  A Reappraisal of Streptococcal Urinary Antigen Testing for Antibiotic Stewardship.

Authors:  Sameer S Kadri
Journal:  Clin Infect Dis       Date:  2020-09-12       Impact factor: 9.079

2.  Changing Epidemiology and Decreased Mortality Associated With Carbapenem-resistant Gram-negative Bacteria, 2000-2017.

Authors:  Ahmed Babiker; Lloyd G Clarke; Melissa Saul; Julie A Gealey; Cornelius J Clancy; M Hong Nguyen; Ryan K Shields
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

3.  Bacteriological Profile and Antimicrobial Susceptibility Patterns of Gram-Negative Bloodstream Infection and Risk Factors Associated with Mortality and Drug Resistance: A Retrospective Study from Shanxi, China.

Authors:  Nan Shi; Jianbang Kang; Shuyun Wang; Yan Song; Donghong Yin; Xiaoxia Li; Qian Guo; Jinju Duan; Shuqiu Zhang
Journal:  Infect Drug Resist       Date:  2022-07-06       Impact factor: 4.177

4.  Clinical Outcomes, Microbiological Characteristics and Risk Factors for Difficult-to-Treat Resistance to Klebsiella pneumoniae Infection.

Authors:  Liyan Cui; Ning Shen; Ping Yang; Chao Liu; Zhenchao Wu; Jiajia Zheng; Juan Yi; Nan Wu; Zhangli Wu; Ming Lu
Journal:  Infect Drug Resist       Date:  2022-10-17       Impact factor: 4.177

5.  Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy.

Authors:  Eric Wenzler; David Butler; Xing Tan; Takayuki Katsube; Toshihiro Wajima
Journal:  Clin Pharmacokinet       Date:  2021-11-18       Impact factor: 5.577

6.  Clinical and Genomic Epidemiology of Carbapenem-Nonsusceptible Citrobacter spp. at a Tertiary Health Care Center over 2 Decades.

Authors:  Ahmed Babiker; Daniel R Evans; Marissa P Griffith; Christi L McElheny; Mohamed Hassan; Lloyd G Clarke; Roberta T Mettus; Lee H Harrison; Yohei Doi; Ryan K Shields; Daria Van Tyne
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

7.  Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals.

Authors:  Sameer S Kadri; Yi Ling Lai; Sarah Warner; Jeffrey R Strich; Ahmed Babiker; Emily E Ricotta; Cumhur Y Demirkale; John P Dekker; Tara N Palmore; Chanu Rhee; Michael Klompas; David C Hooper; John H Powers; Arjun Srinivasan; Robert L Danner; Jennifer Adjemian
Journal:  Lancet Infect Dis       Date:  2020-09-08       Impact factor: 25.071

8.  Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project.

Authors:  Stijn Blot; Massimo Antonelli; Kostoula Arvaniti; Koen Blot; Ben Creagh-Brown; Dylan de Lange; Jan De Waele; Mieke Deschepper; Yalim Dikmen; George Dimopoulos; Christian Eckmann; Guy Francois; Massimo Girardis; Despoina Koulenti; Sonia Labeau; Jeffrey Lipman; Fernando Lipovestky; Emilio Maseda; Philippe Montravers; Adam Mikstacki; José-Artur Paiva; Cecilia Pereyra; Jordi Rello; Jean-Francois Timsit; Dirk Vogelaers
Journal:  Intensive Care Med       Date:  2019-10-29       Impact factor: 17.440

9.  Key Takeaways From the U.S. CDC's 2019 Antibiotic Resistance Threats Report for Frontline Providers.

Authors:  Sameer S Kadri
Journal:  Crit Care Med       Date:  2020-07       Impact factor: 7.598

10.  Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study.

Authors:  Jeffrey R Strich; Sarah Warner; Yi Ling Lai; Cumhur Y Demirkale; John H Powers; Robert L Danner; Sameer S Kadri
Journal:  Lancet Infect Dis       Date:  2020-06-04       Impact factor: 71.421
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.